ClearPoint Neuro (CLPT) Non-Current Assets (2011 - 2026)
ClearPoint Neuro (CLPT) reported Non-Current Assets of $38.5 million for Q1 2026, up 558.11% on a YoY basis from $5.9 million in Q1 2025, and up 12.86% sequentially from $34.1 million in Q4 2025.
ClearPoint Neuro (CLPT) Non-Current Assets (2011 - 2026) Analysis & Trends
ClearPoint Neuro (CLPT) has 16 years of Non-Current Assets data on file, last reported at $38.5 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets rose 558.11% year-over-year to $38.5 million; the trailing twelve-month figure through Mar 2026 stood at $90.6 million (up 284.47% YoY), and the FY2025 full-year result was $34.1 million, up 486.11% from the prior year.
- Non-Current Assets rose to $38.5 million in Q1 2026, from $34.1 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $38.5 million in Q1 2026 to a low of $3.6 million in Q2 2022.
- A 5-year average of $9.4 million and a median of $6.0 million in 2024 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets fell 13.16% in 2024 and jumped 558.11% in 2026, its largest moves.
- Tracing CLPT's Non-Current Assets over 5 years: stood at $4.3 million in 2022, then surged by 50.56% to $6.5 million in 2023, then fell by 10.22% to $5.8 million in 2024, then soared by 486.11% to $34.1 million in 2025, then advanced by 12.86% to $38.5 million in 2026.
- Business Quant data shows CLPT's Non-Current Assets at $38.5 million in Q1 2026, $34.1 million in Q4 2025, and $9.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | ClearPoint Neuro | 434.51 Mn | 398.91 Mn | 7.76 Mn | 38.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.54 Mn |
| Dec 31, 2025 | 34.15 Mn |
| Sep 30, 2025 | 9.03 Mn |
| Jun 30, 2025 | 8.88 Mn |
| Mar 31, 2025 | 5.86 Mn |
| Dec 31, 2024 | 5.83 Mn |
| Sep 30, 2024 | 5.86 Mn |
| Jun 30, 2024 | 6.02 Mn |
| Mar 31, 2024 | 6.07 Mn |
| Dec 31, 2023 | 6.49 Mn |
| Sep 30, 2023 | 6.53 Mn |
| Jun 30, 2023 | 6.93 Mn |
| Mar 31, 2023 | 4.26 Mn |
| Dec 31, 2022 | 4.31 Mn |
| Sep 30, 2022 | 3.92 Mn |
| Jun 30, 2022 | 3.60 Mn |
| Mar 31, 2022 | 3.76 Mn |
| Dec 31, 2021 | 3.69 Mn |
| Sep 30, 2021 | 3.71 Mn |
| Jun 30, 2021 | 3.82 Mn |